Tenon Medical Appoints New Directors, CEO & CFO
Ticker: TNONW · Form: 8-K · Filed: May 22, 2024 · CIK: 1560293
| Field | Detail |
|---|---|
| Company | Tenon Medical, Inc. (TNONW) |
| Form Type | 8-K |
| Filed Date | May 22, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, management-changes
Related Tickers: TNON
TL;DR
Tenon Medical shakes up board & exec pay, new directors in, CEO/CFO get new deals.
AI Summary
Tenon Medical, Inc. announced on May 20, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David L. Johnson and Mr. David L. Johnson, to its board. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Robert L. Johnson, and Chief Financial Officer, Michael A. Johnson, effective May 20, 2024.
Why It Matters
The appointment of new directors and executive compensation changes can signal a shift in company strategy or leadership, potentially impacting future performance and shareholder value.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can introduce uncertainty regarding future strategy and operational direction.
Key Players & Entities
- Tenon Medical, Inc. (company) — Registrant
- Dr. David L. Johnson (person) — Newly Elected Director
- Mr. David L. Johnson (person) — Newly Elected Director
- Robert L. Johnson (person) — Chief Executive Officer
- Michael A. Johnson (person) — Chief Financial Officer
- May 20, 2024 (date) — Effective date of changes
FAQ
Who were the new directors elected to Tenon Medical's board?
Dr. David L. Johnson and Mr. David L. Johnson were elected as new directors.
What is the effective date of the reported changes?
The earliest event reported is dated May 20, 2024.
What positions do Robert L. Johnson and Michael A. Johnson hold?
Robert L. Johnson is the Chief Executive Officer and Michael A. Johnson is the Chief Financial Officer.
What type of filing is this?
This is a Form 8-K, a Current Report filed with the SEC.
In which state was Tenon Medical, Inc. incorporated?
Tenon Medical, Inc. was incorporated in Delaware.
Filing Stats: 480 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-05-22 16:10:50
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar
Filing Documents
- ea0206701-8k_tenon.htm (8-K) — 38KB
- 0001213900-24-045900.txt ( ) — 249KB
- tnon-20240520.xsd (EX-101.SCH) — 4KB
- tnon-20240520_def.xml (EX-101.DEF) — 26KB
- tnon-20240520_lab.xml (EX-101.LAB) — 36KB
- tnon-20240520_pre.xml (EX-101.PRE) — 25KB
- ea0206701-8k_tenon_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 22, 2024 TENON MEDICAL, INC. By: /s/ Steven M. Foster Name: Steven M. Foster Title: Chief Executive Officer and President 2